1. From the Moritz College of Law, the Drug Enforcement and Policy Center, and the James Comprehensive Cancer Center, Ohio State University, Columbus (P.J.Z.); and the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (A.S.).